Search Results for: IMMUNOASSAY PLATFORM Accelerating Drug Development
Articles
January 7, 2016
IMMUNOASSAY PLATFORM – Accelerating Drug Development & Clinical Validation With Single Molecule Counting January 7, 2016
Steven Suchyta, PhD, discusses how Ultrasensitive Single Molecule Counting technology provides an indispensable tool in the researcher’s arsenal to help move novel biology forward, fueling the discovery and development of new therapeutics.
October 2, 2017
Aushon BioSystems & ABL, Inc. Announce Adoption of the Cira Platform October 2, 2017
Aushon BioSystems and ABL, Inc. recently announced that ABL has adopted the Cira platform for multiplex and ultrasensitive biomarker analysis....
February 11, 2013
2/13/2013 February 11, 2013
Frost & Sullivan Sees Urgent Need for Cancer Diagnostics Tests; Finds Unmet Need for Key Disorders The range of potential...
